4 million Canadians suffer from Chronic Kidney Disease and Chronic Renal Failure
Renochlor aids in restoring kidney health and kidney functions naturally.
DIRECTIONS
Adult Dose
Take 10 ml of syrup three times a day.
Suggested Use
On an empty stomach.
Shake well.
SCIENTIFIC EVIDENCE
RENOCHLOR is a novel, patented, clinically proven dietary supplement for improvement of renal functions in patients suffering from Chronic Renal Failure ("CRF"). Renal failure is characterized by loss of the ability of the kidneys to excrete bodily wastes, concentrate urine, conserve electrolytes and maintain fluid balance in the body. Untreated chronic kidney disease (CKD) in absence of change in food habits and medical treatment leads to progressive loss of kidney function considerably fast reaching to the life threatening stage very fast.
The current treatment is dialysis as per requirement ranging from once in a day to once in several weeks. This does not treat the basic cause but helps in eliminating the wastes accumulated in the blood. Dialysis alone does not provide any remedy to declining hemoglobin, which ultimately becomes a major cause for further deterioration and decrease in immunity.
RENOCHLOR has been demonstrated, in several clinical trials, to normalize kidney functions in CRF patients and even prevent the need for expensive and
cumbersome dialysis treatments, with a relative decrease in serum creatinine and increased glomerular filtration rate (GFR) for the entire duration of two months of its administration. The effect of which has also shown to get carried over up to 90 days in case of relative decrease in serum creatinine and increased GFR.
The results obtained are statistically significant also for improvement in practically all aspects of quality of life; which is the most important objective of a CKD treatment that is rarely achieved in currently known CKD treatments prior to the introduction of RENOCHLOR®.
According to the Canadian Kidney Foundation, 1 in 10 Canadians suffer from CKD. According to a 2017 study in the Canadian Journal of Kidney Health and Disease, "of the 4 million Canadian adults living with CKD, 43,00 have end-stage renal disease (ESRD)…which means the Canadian health care system spends nearly $2.5 billion annually caring for the 0,06% of Canadians who are on dialysis. Health care costs for those living with CKD more broadly in Canada exceed $40 billion per year in Canada."